Cost analysis study of commonly used oral hypoglycaemic agents available in India- a pharmacoeconomic study
Journal Title: Indian Journal of Pharmacy and Pharmacology - Year 2017, Vol 4, Issue 1
Abstract
Objectives: To assess the difference in cost percentage variation of various brands of oral hypoglycaemic drugs available in single and in combination in Indian market. Materials and Methods: An observational study was carried out using ‘Current index in medical specialities’, ‘reference Rx’, & ‘Indian drug referral’ (July-Oct 2014), where in the difference in the maximum and minimum price of a particular drug, manufactured by different pharmaceutical companies, in the same strength, number and dosage form was compared and the percentage variation in price was calculated. Data is analysed using descriptive statistical analysis. Results: The minimum and maximum percentage price variation for different classes of drugs respectively is as follows: In Single drug therapy, among sulfonylurea group of drugs, Glimepiride (2mg) & Glicazide (80mg) shows maximum and minimum price variation of 730.93% & 165.55% respectively. Among Biguanides & Thiazolidinediones groups, Metformin (500 mg) & Pioglitazone (15mg) show maximum price variation of 402.92% & 483.33% respectively. In α-glucosidases inhibitor group of drugs, Voglibose (0.2mg) shows maximum price variation of 451.28 %. Among newer DPP4 (Dipeptide peptidase 4) inhibitors Vildagliptin (50mg) shows maximum cost variation of 100%. In combination therapies Glimipiride & Pioglitazone combination shows the maximum variation up to 307.7%. Conclusion: The percentage cost variation of different brands of the same drug manufactured in India is very wide and the reason behind marketing a drug should be directed towards maximizing the benefit of therapy and minimizing negative personal and economic consequences.
Authors and Affiliations
Dharani Devangi R, Rajesh B, Shashirekha CH
Keywords
Related Articles
- EP ID EP295557
- DOI 10.18231/2393-9087.2017.0006
- Views 124
- Downloads 0
Development and Validation of RP-HPLC Method for Simultaneous Estimation of Paracetamol and Tramadol Hydrochloride
A simple and rapid RP-HPLC method has been developed for the simultaneous estimation of paracetamol and tramadol hydrochloride. The chromatographic analysis was carried out on an Enable C18 column (250×4.6 mm i.d., 5µm)...
Wound healing activity of topical formulation of Lantana camara Linn flower water distillate in Wistar rats
Objective: To evaluate the wound healing effect of topical formulation of Lantana camara Linn flower water distillate in Wistar rats. Materials and Methods: The water distillate of Lantana camara Linn flowers were made i...
Evaluation of Anti-inflammatory and Immunosuppressive Activities of Indomethacin in Experimental Animal Models
Background: A potent non selective non-steroidal anti-inflammatory drug(NSAIDs) is indomethacin commonly not used as first line analgesic in clinical practice due to its adverse drug reactions. Acute anti-inflammatory an...
Use of Proton Pump Inhibitors – A drug utilization study
Background: In 2006 PPI was the third most frequently prescribed drug in Australia. In United States, UK and New Zealand similar trends were observed. Utilization of proton pump inhibitors is increasing continuously. Dif...
Comparing palonosetron and lignocaine pretreatment with venous occlusion on reducing rocuronium associated withdrawal movements. A double blinded randomized control trial
Introduction Use of rocuronium has been associated with withdrawal movements of injected arm during its administration Our study is to compare the effectiveness of palonosetron vs lignocaine pretreatment with venous occl...